WALTHAM – Deniz Goodman, a student at the Boston University School of Medicine, has been named the recipient of the Massachusetts Medical Society’s 2023 Information Technology Award.
The honor recognizes the development of an information technology tool that helps physicians practice medicine, teach medicine, or pursue clinical research.
This year, the award is sponsored by Click Therapeutics, Inc., (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments and comes with a $5,000 award.
The MMS Information Technology in Medicine Award has been presented annually since 2001 and many winners have seen their projects make indelible marks on science, medicine, and patient care.
Goodman’s award-winning work focused on the development of an ultrasound simulator application aimed at teaching the kinesthetic handling of various ultrasound transducers via point-of-care ultrasound probe motion and scanning simulation. The smartphone
app boasts self-guided modules for individual ultrasound views, designed to enable remote learning in the context of the COVID-19 pandemic. “Although point-of-care ultrasound has historically been taught through an in-person clinical curriculum,
our app will allow students to learn from anywhere—free of geographical or financial constraints. I envision it being of particular benefit to students without local access to ultrasound machines, which can cost upwards of several thousands of
dollars,” Goodman explained.
Goodman completed his undergraduate studies through the Boston University accelerated medical program with a double major in psychology and medical science. He was one of 4 fellows selected to join the Bascom Palmer Eye Institute’s Student Outreach
and Research Fellowship for the class of 2024 and was also one of 30 scholars chosen for the Health Equity Leaders Program class of 2023.
Goodman’s involvement in the Massachusetts Medical Society dates back to the beginning of his medical school career. In 2022, he became the first medical student to be elected into an executive position on one of the medical society’s committees,
serving as Vice-Chair of the Committee on LGBTQ Matters.
In early 2023, Goodman presided as Chair of the New England Journal of Medicine Research Symposium, sponsored by the NEJM Group, a division of the MMS. He also played an important role in the medical society’s policy-making body, serving on the Reference
Committee A, Public Health, and the Late & Deferred Committee for the House of Delegates. He was additionally selected to represent the Suffolk District in the MMS annual meeting and will be representing Massachusetts in the American Medical Association
Medical Student Section.
During the upcoming academic year, Goodman will serve a 1-year term as Clinical Governing Councilor of the MMS Medical Student Section. He will also join the Committee on Legislation, through which he aims to advocate for patients and physicians by
effecting legislative change at the state level.
In addition to his leadership in organized medicine, Goodman has a longstanding commitment to promoting health equity through service and research. He is particularly interested in identifying and addressing disparities within the field of ophthalmology
and has co-founded the Boston Sight Savers organization to establish vision screenings at homeless shelters in his community. He was awarded the MMS Community Service Grant in support of this initiative and, as director of the organization, he
aims to reduce the disease burden of glaucoma among the homeless South Boston population by identifying barriers to routine vision care and connecting at-risk individuals with glaucoma specialists.
The Massachusetts Medical Society (MMS) is the statewide professional association for physicians and medical students, supporting 25,000 members. We are dedicated to educating and advocating for the physicians of Massachusetts and patients locally and nationally. A leadership voice in health care, the MMS contributes physician and patient perspectives to influence health-related legislation at the state and federal levels, works in support of public health, provides expert advice on physician practice management, and addresses issues of physician well-being. Under the auspices of the NEJM Group, the MMS extends our mission globally by advancing medical knowledge from research to patient care through the New England Journal of Medicine, NEJM Catalyst, and the NEJM Journal Watch family of specialty publications, and through our education products for health care professionals: NEJM Knowledge+, NEJM Resident 360, and our accredited and comprehensive continuing medical education programs.
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Click is progressing a broad pipeline of Digital Therapeutics™ across a variety of high-burden therapeutic areas, including Major Depressive Disorder, Schizophrenia, Migraine, Multiple Sclerosis, Chronic Pain, Atopic Dermatitis, Acute Coronary Syndrome, Obesity, Oncology and more. For more information on Click, visit ClickTherapeutics.com.
